8-KRegulation FD

Elevance Health, Inc. 8-K Report, Regulation FD Disclosure (Mar 20, 2006)

Filed March 20, 2006For Securities:ELV

Summary

Elevance Health, Inc. (then operating as WellPoint, Inc.) issued this Form 8-K on March 20, 2006, to provide forward-looking guidance regarding upcoming meetings with securities analysts and investors. The primary purpose of this filing was to confirm the company's confidence in meeting previously issued earnings expectations. These expectations were originally communicated on January 25, 2006, through a press release and conference call, the details of which were furnished in a prior 8-K filing. This report signals management's proactive approach to investor relations, aiming to maintain market confidence by reiterating financial targets. Investors should note that the information provided in this 8-K is for disclosure purposes under Regulation FD and is not considered "filed" for purposes of liability under Section 18 of the Exchange Act or incorporated into other SEC filings.

Key Highlights

  • 1WellPoint, Inc. (now Elevance Health) is confirming its ability to meet previously provided earnings expectations.
  • 2The confirmation is made in anticipation of upcoming meetings with securities analysts and investors scheduled from March 20, 2006, to April 5, 2006.
  • 3The earnings expectations were initially set on January 25, 2006, via a press release and conference call.
  • 4This filing is made under Regulation FD to ensure broad dissemination of material information.
  • 5The information furnished in this report is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
  • 6The disclosure is intended to provide transparency and maintain investor confidence in the company's financial performance.

Frequently Asked Questions